Richard A. Richieri - 25 Dec 2024 Form 4 Insider Report for Avid Bioservices, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Dec 2024, 19:31:02 UTC
Prior SEC filing
11 Oct 2024
Next SEC filing
02 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Stephen Hedberg, by Power of Attorney for Richard A. Richieri

Key filing fact

Richard A. Richieri filed Form 4 for Avid Bioservices, Inc. on 27 Dec 2024.

Key facts

  • This page summarizes Richard A. Richieri's Form 4 filing for Avid Bioservices, Inc..
  • 6 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 27 Dec 2024, 19:31.

Change

  • Previous filing in this sequence was filed on 11 Oct 2024.
  • Current net transaction value: -$46,961.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDMO transaction

Common Stock, $0.001 par value

Options Exercise

Transaction value
Shares
+10,695
Change %
+28%
Price
Shares after
48,399
Date
25 Dec 2024
Ownership
Direct
Footnotes
F1, F2
CDMO transaction

Common Stock, $0.001 par value

Sale

Transaction value
$46,961
Shares
-3,843
Change %
-7.9%
Price
$12.22
Shares after
44,556
Date
26 Dec 2024
Ownership
Direct
Footnotes
F3
CDMO holding

Common Stock, $0.001 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,218
Date
25 Dec 2024
Ownership
By Spouse

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDMO transaction Derivative

Performance Stock Units (FY 2023 Grant)

Disposed to Issuer

Transaction value
$0
Shares
-5,043
Change %
-3.9%
Price
$0.000000
Shares after
123,485
Date
25 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,043
Exercise price
Footnotes
F2, F4, F5
CDMO transaction Derivative

Performance Stock Units (FY 2023 Grant)

Disposed to Issuer

Transaction value
$0
Shares
-5,044
Change %
-4.1%
Price
$0.000000
Shares after
118,441
Date
25 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,044
Exercise price
Footnotes
F2, F4, F6
CDMO transaction Derivative

Performance Stock Units (FY 2024 Grant)

Disposed to Issuer

Transaction value
$0
Shares
-5,652
Change %
-4.8%
Price
$0.000000
Shares after
112,789
Date
25 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,652
Exercise price
Footnotes
F2, F4, F5
CDMO transaction Derivative

Performance Stock Units (FY 2024 Grant)

Disposed to Issuer

Transaction value
$0
Shares
-5,652
Change %
-5%
Price
$0.000000
Shares after
107,137
Date
25 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,652
Exercise price
Footnotes
F2, F4, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

In connection with the anticipated transactions contemplated by the Agreement and Plan of Merger (the "Merger Agreement") whereby the Issuer will be acquired by funds managed by affiliates of GHO Capital Partners LLP and Ampersand Capital Partners, the Board of Directors of the Issuer accelerated the payment of certain equity awards in connection with certain actions to mitigate adverse tax consequences of Section 280G and Section 4999 of the Internal Revenue Code of 1986 (as amended) that could arise in connection with the anticipated transactions under the Merger Agreement. The accelerated settlement of equity awards reported in this Form 4 was contingent upon the reporting person's agreement to repay accelerated compensation amounts under certain conditions.

Footnote F2

Each performance stock unit ("PSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.

Footnote F3

Represents the shares sold by the reporting person pursuant to a contractual election to satisfy tax withholding obligations in connection with the vesting of the PSUs described in footnotes 4 and 5. This sale does not represent a discretionary trade by the reporting person.

Footnote F4

The PSUs granted to the reporting person were subject to the Issuer achieving certain fiscal year financial milestones over three (3) consecutive fiscal year performance periods (i.e., May 1 to April 30) commencing with the fiscal year in which the PSU was initially granted (each fiscal year a "Performance Period"). Subject to the Issuer attaining the applicable fiscal year milestones, 1/3rd of the PSUs were scheduled to vest on the last day of each fiscal year during the Performance Period, subject to the reporting person's continuous service to the Issuer on such vesting dates. The number of PSUs initially reported by the reporting person was based on a maximum 200% achievement of each milestone during each Performance Period (the "Maximum Performance Target"). If a milestone was achieved at a rate below the Maximum Performance Target, or was not achieved, the corresponding portion of the PSUs that did not vest would be forfeited.

Footnote F5

Vested PSUs settled into shares of the Issuer's Common Stock on December 25, 2024.

Footnote F6

Represents the forfeiture of unearned PSUs for the Performance Period ending April 30, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .